financetom
Business
financetom
/
Business
/
Market Chatter: Microsoft-backed OpenAI Attracting Nvidia, Apple in $6.5 Billion Funding Round, Reuters Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Microsoft-backed OpenAI Attracting Nvidia, Apple in $6.5 Billion Funding Round, Reuters Says
Sep 16, 2024 3:06 AM

05:11 AM EDT, 09/16/2024 (MT Newswires) -- Microsoft ( MSFT ) -back OpenAI is drawing interest from new investors Nvidia ( NVDA ) and Apple ( AAPL ) in a $6.5 billion round of financing that aims to value the generative artificial intelligence firm at $150 billion, Reuters reported Friday, citing unnamed sources with direct knowledge of the matter.

Sequoia Capital is also in discussions to come back as a returning investor, according to the report.

Reuters said the latest financing is expected to come in convertible notes and the funding will hinge on whether the company removes lingering non-profit features of its corporate structure, including the removal of a profit cap.

OpenAI did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 430.35, Change: -0.24, Percent Change: -0.06

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Regeneron Shares Down After FDA Letter Questioning Application for Potential Lymphoma Treatment
Regeneron Shares Down After FDA Letter Questioning Application for Potential Lymphoma Treatment
Mar 25, 2024
09:52 AM EDT, 03/25/2024 (MT Newswires) -- Regeneron Pharmaceuticals' ( REGN ) shares were down nearly 1 percent in early trading Monday after it received negative feedback from the Food and Drug Administration regarding its Biologics License Application for odronextamab, a potential treatment for relapsed or refractory forms of both follicular lymphoma and diffuse large B-cell lymphoma. The company said...
Core Molding Technologies Names Eric L. Palomaki COO
Core Molding Technologies Names Eric L. Palomaki COO
Mar 25, 2024
09:49 AM EDT, 03/25/2024 (MT Newswires) -- Core Molding Technologies ( CMT ) said Monday it has named Eric L. Palomaki as chief operating officer. The company said Palomaki previously served as Core Molding's ( CMT ) executive vice president of operations, research and development. Price: 19.01, Change: +0.29, Percent Change: +1.55 ...
Cryo-Cell International to Spin Off Celle Unit, Explore Strategic Alternatives; Shares Jump
Cryo-Cell International to Spin Off Celle Unit, Explore Strategic Alternatives; Shares Jump
Mar 25, 2024
09:56 AM EDT, 03/25/2024 (MT Newswires) -- Cryo-Cell International ( CCEL ) said Monday that its board has approved the spinoff of its Celle unit to the company's shareholders and the move to look into strategic alternatives for Cryo-Cell ( CCEL ) post-spinoff, including a possible sale or merger. The spinoff of the newly created Celle unit is expected to...
Captivision Appoints Gary Garrabrant as CEO
Captivision Appoints Gary Garrabrant as CEO
Mar 25, 2024
09:51 AM EDT, 03/25/2024 (MT Newswires) -- Captivision ( CAPT ) said Monday it has appointed Gary Garrabrant as chair and chief executive, effective immediately. Former CEO Ho Joon Lee will become chief technology officer, the company said. Price: 6.39, Change: +0.05, Percent Change: +0.79 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved